Lang Matthew's Form 4 filing
Myovant Sciences Ltd. (MYOV) · filed Aug 16, 2022
- Accession no.
- 0001209191-22-046001
- Filed
- Aug 16, 2022
- Trade date
- Aug 12-15, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $569.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lang MatthewCIK 0001712069 | Officer (General Counsel & Corp. Secy.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Shares | AGrant or awardAcquired | +124,780 | $0.00 | $0 | 395,180 | Direct | |
| Aug 15, 2022 | Common Shares | SSaleDisposed | −31,214 | $18.23F4 | −$569,031.22 | 363,966 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The shares were sold at prices ranging from $18.22 to $18.23. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.